Dr. Memarzadeh on Hormonal Therapy for Endometrial Tumors

Video

Sanaz Memarzadeh, MD, associate professor of obstetrics and gynecology and the director of the Gynecologic Oncology (GO) discovery Lab at UCLA, discusses the benefits of hormonal therapy for endometrial tumors.

Sanaz Memarzadeh, MD, PhD associate professor of obstetrics and gynecology and the director of the Gynecologic Oncology (GO) discovery Lab at UCLA, discusses the benefits of hormonal therapy for endometrial tumors.

Endometrial tumors are hormonally regulated, but hormonal therapy is not widely used to treat this subtype. This is mainly due to a lack of understanding of its effects, said Memarzadeh.

Memarzadeh’s team determined that supporting stromal cells surrounding an endometrial tumor which are most commonly ignored, are the cells that exert the progesterone anti-cancer effects.

Related Videos
Saad Z. Usmani, MD, MBA, FACP, FASCO
Rebecca Kristeleit, BSc, MBChB, MRCP, PhD
Don S. Dizon, MD
Rohan Garje, MD
Sarah E. S. Leary, MD, MS, attending physician, medical director, Pediatric Brain Tumor Program, Seattle Children’s Hospital; professor, Department of Pediatrics, University of Washington School of Medicine
Samer A. Srour, MB ChB, MS
Rita Nanda, MD
Vikram Narayan, MD
Daniel Olson, MD
Vishal Patel, MD, FAAD, FACMS, associate professor, Dermatology, George Washington (GW) School of Medicine & Health Sciences